Heart 2008;94:1256-1257
EDITORIALS
NICE lipid modification guideline: both absolute and obsolete!
Professor Anders G Olsson, University of Linköping, Sweden; andol@imv.liu.se
| The first 150 words of the full text of this article appear below. |
Guidelines for the prevention of cardiovascular disease (CVD) are greatly time-dependent owing to the rapid increase in knowledge in this important research area. However, at each point in time the knowledge base behind all guidelines on CVD prevention—for example, blood lipid modification, is common, international and easily available to all clinical scientists and opinion leaders engaged in the formulation of these guidelines. Nevertheless, they differ markedly between continents, countries and regions. There are several reasons for this: from factual differences in risk factor distribution between different populations to local customs and traditions and individual influences from scientists and clinicians involved in the authorship of the guidelines. Recently a new guideline for lipid modification by the National Institute for Health and Clinical Excellence in the United Kingdom was issued (see page 1331).1 2 And last year the Fourth Joint Task Force of the European Society of Cardiology and Other Societies
Relevant Article
- Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
- J Robson
Heart 2008 94: 1331-1332.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
